JP2024164022A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024164022A5 JP2024164022A5 JP2024122108A JP2024122108A JP2024164022A5 JP 2024164022 A5 JP2024164022 A5 JP 2024164022A5 JP 2024122108 A JP2024122108 A JP 2024122108A JP 2024122108 A JP2024122108 A JP 2024122108A JP 2024164022 A5 JP2024164022 A5 JP 2024164022A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- weight
- compound
- treatment
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 6
- 206010014989 Epidermolysis bullosa Diseases 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- 239000002245 particle Substances 0.000 claims 2
- TYNLGDBUJLVSMA-UHFFFAOYSA-N 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid Chemical compound O=C1C2=CC(C(O)=O)=CC(OC(C)=O)=C2C(=O)C2=C1C=CC=C2OC(=O)C TYNLGDBUJLVSMA-UHFFFAOYSA-N 0.000 claims 1
- 229960000541 cetyl alcohol Drugs 0.000 claims 1
- 229960004590 diacerein Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 235000019271 petrolatum Nutrition 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
- 239000003871 white petrolatum Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187743P | 2015-07-01 | 2015-07-01 | |
| US62/187,743 | 2015-07-01 | ||
| JP2017568131A JP7577428B2 (ja) | 2015-07-01 | 2016-06-30 | ジアセレインまたはレインの局所製剤およびその使用 |
| PCT/US2016/040287 WO2017004319A1 (en) | 2015-07-01 | 2016-06-30 | Diacerein or rhein topical formulations and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017568131A Division JP7577428B2 (ja) | 2015-07-01 | 2016-06-30 | ジアセレインまたはレインの局所製剤およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024164022A JP2024164022A (ja) | 2024-11-26 |
| JP2024164022A5 true JP2024164022A5 (https=) | 2025-03-21 |
Family
ID=57609470
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017568131A Active JP7577428B2 (ja) | 2015-07-01 | 2016-06-30 | ジアセレインまたはレインの局所製剤およびその使用 |
| JP2022125318A Active JP7578651B2 (ja) | 2015-07-01 | 2022-08-05 | ジアセレインまたはレインの局所製剤およびその使用 |
| JP2024122108A Pending JP2024164022A (ja) | 2015-07-01 | 2024-07-29 | ジアセレインまたはレインの局所製剤およびその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017568131A Active JP7577428B2 (ja) | 2015-07-01 | 2016-06-30 | ジアセレインまたはレインの局所製剤およびその使用 |
| JP2022125318A Active JP7578651B2 (ja) | 2015-07-01 | 2022-08-05 | ジアセレインまたはレインの局所製剤およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9744131B2 (https=) |
| EP (1) | EP3316879A4 (https=) |
| JP (3) | JP7577428B2 (https=) |
| KR (1) | KR102702557B1 (https=) |
| CN (2) | CN117482078A (https=) |
| AU (2) | AU2016287636B2 (https=) |
| CA (1) | CA2990948C (https=) |
| HK (1) | HK1249057A1 (https=) |
| IL (1) | IL256585B (https=) |
| MX (1) | MX373702B (https=) |
| TW (1) | TWI723032B (https=) |
| WO (1) | WO2017004319A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10195170B2 (en) * | 2015-08-17 | 2019-02-05 | Twi Biotechnology, Inc. | Methods for inhibiting expression of ASC, expression of NLRP3, and/or formation of NLRP3 inflammasome complex using diacerein or its analogs |
| JP2020505362A (ja) * | 2017-01-19 | 2020-02-20 | ティダブリューアイ・バイオテクノロジー・インコーポレイテッドＴＷＩ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． | 免疫炎症性皮膚障害を予防または治療するための方法および医薬組成物 |
| CN106692037B (zh) * | 2017-01-24 | 2020-02-18 | 中南大学湘雅医院 | 大黄酸超分子水凝胶及其制备方法和应用 |
| CN107823126B (zh) * | 2017-12-04 | 2020-03-24 | 广东药科大学 | 双醋瑞因注射型温敏凝胶及其制备方法 |
| WO2020114444A1 (zh) * | 2018-12-05 | 2020-06-11 | 中检科医药科技(北京)集团有限公司 | 双醋瑞因在制备抗病毒药物及治疗病毒感染中的用途 |
| CN109758421A (zh) * | 2019-03-27 | 2019-05-17 | 毕波 | 一种蓝氧抗菌灭毒软膏及其制备方法 |
| US20220265577A1 (en) * | 2019-08-03 | 2022-08-25 | Venkateswarlu Vobalaboina | Process for the preparation of anthraquinone topical formulation |
| CN110585120B (zh) * | 2019-10-08 | 2020-11-27 | 中南大学 | 一种可注射双醋瑞因水凝胶及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4018764B2 (ja) * | 1996-10-18 | 2007-12-05 | 正規 小菅 | 津液改善用皮膚外用剤 |
| FR2757397B1 (fr) * | 1996-12-23 | 1999-03-05 | Mazal Pharma | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree |
| US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
| US20100285114A1 (en) * | 2007-09-27 | 2010-11-11 | Rahul Dabre | Pharmaceutical compositions of rhein or diacerein |
| WO2009047562A1 (en) * | 2007-10-08 | 2009-04-16 | Serentis Limited | Methods and compositions for the treatment of pruritus |
| WO2009133430A1 (en) | 2008-04-30 | 2009-11-05 | Wockhardt Research Centre | Topical compositions of rhein or diacerein |
| TWI473610B (zh) * | 2008-10-28 | 2015-02-21 | Twi Biotechnology Inc | 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物 |
| FR2949044B1 (fr) * | 2009-08-12 | 2021-05-07 | Expanscience Lab | Composition comprenant une fraction d'insaponifiable |
| KR101567925B1 (ko) | 2010-04-08 | 2015-11-10 | 티더블유아이 바이오테크놀로지 인코포레이티드 | 당뇨병 보조치료요법으로서 디아세레인을 사용하는 방법 |
| EP2598536A1 (en) * | 2010-07-29 | 2013-06-05 | Université de Genève | Process for the esterification of hyaluronic acid with hydrophobic organic compounds |
| CN103429236B (zh) | 2011-03-11 | 2016-09-21 | 安成生物科技股份有限公司 | 治疗高尿酸血症和与高尿酸血症相关的代谢性病症的方法和组合物 |
-
2016
- 2016-06-30 MX MX2018000264A patent/MX373702B/es active IP Right Grant
- 2016-06-30 KR KR1020187002677A patent/KR102702557B1/ko active Active
- 2016-06-30 CN CN202311670907.4A patent/CN117482078A/zh active Pending
- 2016-06-30 EP EP16818753.2A patent/EP3316879A4/en active Pending
- 2016-06-30 HK HK18108955.6A patent/HK1249057A1/zh unknown
- 2016-06-30 CA CA2990948A patent/CA2990948C/en active Active
- 2016-06-30 JP JP2017568131A patent/JP7577428B2/ja active Active
- 2016-06-30 US US15/198,728 patent/US9744131B2/en active Active
- 2016-06-30 WO PCT/US2016/040287 patent/WO2017004319A1/en not_active Ceased
- 2016-06-30 CN CN201680050004.8A patent/CN107921013A/zh active Pending
- 2016-06-30 AU AU2016287636A patent/AU2016287636B2/en active Active
- 2016-07-01 TW TW105120973A patent/TWI723032B/zh active
-
2017
- 2017-12-26 IL IL256585A patent/IL256585B/en active IP Right Grant
-
2021
- 2021-09-08 AU AU2021229177A patent/AU2021229177B2/en active Active
-
2022
- 2022-08-05 JP JP2022125318A patent/JP7578651B2/ja active Active
-
2024
- 2024-07-29 JP JP2024122108A patent/JP2024164022A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024164022A5 (https=) | ||
| JP2018522875A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| CN1230159C (zh) | 必需脂肪酸在预防心血管疾病中的应用 | |
| EP0085579A2 (en) | Topical pharmaceutical compositions | |
| JP2023503071A5 (https=) | ||
| JP2023109826A5 (https=) | ||
| JP2010506900A5 (https=) | ||
| JPH0369887B2 (https=) | ||
| WO2013026557A1 (de) | Vasokonstriktorhaltiges kombinationstherapeutikum | |
| US3934028A (en) | Acne and psoriasis treatment with retinoic acid analogs | |
| JPH0892180A (ja) | Ｌ−カルニチン塩および化粧用および皮膚病処置用医薬組成物 | |
| JP5737888B2 (ja) | アトピー性皮膚炎治療剤 | |
| US4346109A (en) | Method of treating keratotic skin disease | |
| WO2016181355A1 (en) | Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity | |
| JP2024536581A5 (https=) | ||
| JP2022517902A5 (https=) | ||
| HRP20241621T1 (hr) | (1r,3s)-3-((5-cijano-4-feniltiazol-2-il)karbamoil)ciklopentan-1-karboksilna kiselina, namijenjena upotrebi u liječenju bolesti dišnih puteva | |
| CN103127166B (zh) | 一种治疗面部痤疮的药物 | |
| JPH0892181A (ja) | Ｌ−カルニチン塩および化粧用および皮膚病処置用医薬組成物 | |
| JP2010509240A (ja) | 喘息、アレルギー性鼻炎および皮膚障害の治療方法 | |
| CN104771408B (zh) | 三七皂苷Ft1的用途 | |
| KR20170043484A (ko) | 천연물 유래 유효성분을 고함량으로 포함하는 관절염의 치료 또는 개선용 약학 조성물 | |
| US20070248555A1 (en) | Composition and method for managing redness of skin associated with dermatological condition | |
| JP2021169472A5 (https=) |